Organic cations
Medchemexpress LLC Aurothiomalate tetramer (sodium) | 12244-57-4 | MFCD00064304 | 98.0% | 390.08 g·mol-1 | C4H6O4S·Au·xNa | 25 MG
Aurothiomalate sodium is a gold-containing anti-rheumatic reagent used in research to inhibit PKCι signaling and thioredoxin reductase. Supplied as a powder for biochemical and cell-based studies, it is used to probe redox biology and oncogenic signaling pathways.
- Purity: 98.0%
- Gold-containing thiomalate compound for biochemical research
- Inhibits PKCι signaling and thioredoxin reductase
- Suitable for cell-based assays and mechanistic studies
- Available in small milligram pack sizes for laboratory use
- Store according to the safety data sheet to preserve stability
Medchemexpress LLC 1-oleoyl lysophosphatidic acid sodium | 325465-93-8 | MFCD00133427 | 99.8% | 458.50 g/mol | C21H40NaO7P | 50 MG
1-Oleoyl lysophosphatidic acid sodium is a bioactive lysophospholipid research reagent that activates lysophosphatidic acid (LPA) receptors and is used in cell-based studies of signaling, proliferation, and neurological responses.
- Acts as a potent agonist of LPA receptors.
- Promotes DNA synthesis and cell proliferation.
- High purity (99.8%).
- Chemical formula C21H40NaO7P; molecular weight 458.50 g/mol.
- Solid form; store at -20°C, in solvent store at -80°C for long-term.
- Available in small research pack sizes, including 50 MG.
Medchemexpress LLC 1-oleoyl lysophosphatidic acid sodium | 325465-93-8 | MFCD00133427 | 99.8% | 458.50 g/mol | C21H40NaO7P | 25 MG
1-Oleoyl lysophosphatidic acid sodium is the sodium salt of a bioactive lysophospholipid that activates lysophosphatidic acid (LPA) receptors. It is provided as a high-purity research reagent for studies of LPA signaling, receptor pharmacology, and cell-based assays.
- High purity 99.8%.
- Molecular formula C21H40NaO7P; molecular weight 458.50 g/mol.
- Includes analytical documentation such as COA, HNMR, CNMR, RP-HPLC, and MS.
- Supplied in small research pack sizes, e.g., 5 mg to 100 mg.
- Suitable for receptor pharmacology and cell signaling assays.
Apexbio Technology LLC DEFERASIROX-FE3-CHELATE-10MG
Deferasirox Fe3 chelate (CAS No 554435-83-5) is a critical compound in biomedical research primarily used in the study of iron overload disorders Originating from studies on iron chelation therapy its mechanism of action involves binding free iron ions to form a stable complex thereby preventing iron-mediated oxidative stress This chelation process targets pathways associated with iron homeostasis In vitro Deferasirox Fe3 chelate demonstrates activity in the nanomolar to low micromolar range indicating potent binding efficiency It is commonly applied in research using various cell models and animal studies to assess its efficacy and safety in chelation therapy contexts The compound is also utilized in drug screening efforts to develop treatments for conditions like thalassemia and sickle cell disease Experimental concentrations typically depend on the specific research design allowing flexibility in application across diverse experimental settings
Apexbio Technology LLC DEFERASIROX-FE3-CHELATE-25MG
Deferasirox Fe3 chelate (CAS No 554435-83-5) is a critical compound in biomedical research primarily used in the study of iron overload disorders Originating from studies on iron chelation therapy its mechanism of action involves binding free iron ions to form a stable complex thereby preventing iron-mediated oxidative stress This chelation process targets pathways associated with iron homeostasis In vitro Deferasirox Fe3 chelate demonstrates activity in the nanomolar to low micromolar range indicating potent binding efficiency It is commonly applied in research using various cell models and animal studies to assess its efficacy and safety in chelation therapy contexts The compound is also utilized in drug screening efforts to develop treatments for conditions like thalassemia and sickle cell disease Experimental concentrations typically depend on the specific research design allowing flexibility in application across diverse experimental settings
Apexbio Technology LLC DEFERASIROX-FE3-CHELATE-2MG
Deferasirox Fe3 chelate (CAS No 554435-83-5) is a critical compound in biomedical research primarily used in the study of iron overload disorders Originating from studies on iron chelation therapy its mechanism of action involves binding free iron ions to form a stable complex thereby preventing iron-mediated oxidative stress This chelation process targets pathways associated with iron homeostasis In vitro Deferasirox Fe3 chelate demonstrates activity in the nanomolar to low micromolar range indicating potent binding efficiency It is commonly applied in research using various cell models and animal studies to assess its efficacy and safety in chelation therapy contexts The compound is also utilized in drug screening efforts to develop treatments for conditions like thalassemia and sickle cell disease Experimental concentrations typically depend on the specific research design allowing flexibility in application across diverse experimental settings
Apexbio Technology LLC DEFERASIROX-FE3-CHELATE-5MG
Deferasirox Fe3 chelate (CAS No 554435-83-5) is a critical compound in biomedical research primarily used in the study of iron overload disorders Originating from studies on iron chelation therapy its mechanism of action involves binding free iron ions to form a stable complex thereby preventing iron-mediated oxidative stress This chelation process targets pathways associated with iron homeostasis In vitro Deferasirox Fe3 chelate demonstrates activity in the nanomolar to low micromolar range indicating potent binding efficiency It is commonly applied in research using various cell models and animal studies to assess its efficacy and safety in chelation therapy contexts The compound is also utilized in drug screening efforts to develop treatments for conditions like thalassemia and sickle cell disease Experimental concentrations typically depend on the specific research design allowing flexibility in application across diverse experimental settings
Apexbio Technology LLC DEFERASIROX-FE3-CHELATE-50MG
Deferasirox Fe3 chelate (CAS No 554435-83-5) is a critical compound in biomedical research primarily used in the study of iron overload disorders Originating from studies on iron chelation therapy its mechanism of action involves binding free iron ions to form a stable complex thereby preventing iron-mediated oxidative stress This chelation process targets pathways associated with iron homeostasis In vitro Deferasirox Fe3 chelate demonstrates activity in the nanomolar to low micromolar range indicating potent binding efficiency It is commonly applied in research using various cell models and animal studies to assess its efficacy and safety in chelation therapy contexts The compound is also utilized in drug screening efforts to develop treatments for conditions like thalassemia and sickle cell disease Experimental concentrations typically depend on the specific research design allowing flexibility in application across diverse experimental settings
Medchemexpress LLC BAY-6035 | 2247890-13-5 | 99.51% | 396.48 | 500 MG
BAY-6035 is a chemical probe that acts as a potent, selective, and substrate-competitive inhibitor of SMYD3. It inhibits the methylation of MEKK2 peptide with an IC50 of 88 nM.
- Potent, selective, and substrate-competitive inhibitor of SMYD3
- Inhibits methylation of MEKK2 peptide
- Shows more than 100-fold selectivity over other histone methyltransferases
- Inhibits the methylation of MEKK2 in cells
Medchemexpress LLC BAY-6035 | 2247890-13-5 | 99.51% | 396.48 | 1 ML
BAY-6035 is a chemical probe and a potent, selective, and substrate-competitive inhibitor of SMYD3. It inhibits the methylation of MEKK2 peptide with an IC50 of 88 nM.
- Potent, selective, and substrate-competitive inhibitor of SMYD3.
- Inhibits methylation of MEKK2 peptide with an IC50 of 88 nM.
- Exhibits more than 100-fold selectivity over other histone methyltransferases.
- Inhibits the methylation of MEKK2 in cells with an IC50 of 70 nM.
Medchemexpress LLC HY-100530 1mg Medchemexpress, Rp-cAMPS (triethylammonium salt) CAS:151837-09-1 Purity:>98%
Medchemexpress, HY-100530 1mg Rp-cAMPS (triethylammonium salt) CAS:151837-09-1 Rp-cAMPS triethylammonium salt is an analog of cAMP which acts as a potent, competitive and cell-permeable antagonist of cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 6.05 µM and 9.75 µM, respectively). Rp-cAMPS triethylammonium salt is resistant to hydrolysis by phosphodiesterases[3][4][5]. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC BAY-6035 | 2247890-13-5 | 99.5% | 396.48 | 25 MG
BAY-6035 is a chemical probe that acts as a potent, selective, and substrate-competitive inhibitor of SMYD3. It inhibits the methylation of MEKK2 peptide with an IC50 of 88 nM. It also demonstrates selective inhibition over other histone methyltransferases.
- Potent and selective SMYD3 inhibitor
- Substrate-competitive inhibition of SMYD3
- Inhibits methylation of MEKK2 peptide with an IC50 of 88 nM
- Exhibits over 100-fold selectivity compared to other histone methyltransferases
- Shows antiproliferative activity against various human cell lines
Medchemexpress LLC Sodium aurothiomalate | 12244-57-4 | MFCD00064304 | 98.0% | 371.11 g/mol | C4H6O4S.Au.xNa | 50 MG
Aurothiomalate sodium is a gold-containing compound used in research as a selective inhibitor of oncogenic PKCι signaling and as a thioredoxin reductase (TrxR) inhibitor. Historically used as an anti-rheumatic agent, it has reported anti-tumor activity and is applied in biochemical and cell-based studies.
- Potent inhibitor of PKCι signaling and thioredoxin reductase
- Shows anti-tumor and anti-inflammatory activity in studies
- Supplied as a solid, off-white to light yellow material
- Typical purity around 98.0%
- Stable under refrigerated, sealed storage away from moisture
- Available in small milligram quantities for research use